chevron_leftBack
As of 2 July 2026, Taiwan Bio Therapeutics Co., Ltd. has a market cap of $71.82M USD, ranking #27877 globally and #1610 in Taiwan.
It ranks #2512 in the Healthcare sector, and #486 in the Biotechnology industry.
Key Stats
Market Cap
$71.82MUSD
2.28B TWD
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
Founded
2014
Website
twbio-thera.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -4.1% | 2.7% | -3.6% | -8.2% | -12% | -15% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
6892
台寶生醫股份有限公司
ISIN: TW0006892003
Shares Out.:
Shares Outstanding:
84.605M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
25.90 TWD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Taiwan Bio Therapeutics Co., Ltd.
Taiwan Bio Therapeutics Co., Ltd., regenerative medicine company, focuses on the development of new cell medicines. It offers medicines for degenerative diseases, cardiovascular diseases, diabetes complications, and autoimmune diseases. The company was founded in 2014 and is based in Taipei, Taiwan.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TWSE: 6919
|
$5.43B
7K%
172.76B TWD
|
-
|
|
TWSE: 6949
|
$1.6B
2K%
50.93B TWD
|
-
|
|
TPEX: 6696
|
$1.07B
1K%
34.04B TWD
|
-
|
|
TWSE: 7827
|
$752.73M
948%
23.94B TWD
|
-
|
|
|
TPEX: 7827
|
$596.74M
731%
18.98B TWD
|
-
|
|
TPEX: 06891
|
$567.92M
691%
18.06B TWD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
254K%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
223K%
|
19.0
|
|
EBR: ARGX
|
$47.27B
66K%
41.39B EUR
|
39.9
|
|
KRX: 207940
|
$44.08B
61K%
68.19T KRW
|
35.5
|
|
SIX: LONN
|
$41.71B
58K%
33.71B CHF
|
37.2
|
|
ASX: CSL
|
$41.71B
58K%
60.27B AUD
|
29.3
|
chevron_leftBack